164 related articles for article (PubMed ID: 31755479)
21. Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris: A Single-Arm Trial.
Haynes D; Strunck JL; Topham CA; Ortega-Loayza AG; Kent G; Cassidy PB; Hu R; Choate K; Wang Z; Liu Y; Greiling TM
JAMA Dermatol; 2020 Jun; 156(6):668-675. PubMed ID: 32293641
[TBL] [Abstract][Full Text] [Related]
22. [Molecular identification of the PSORS2 locus: mutations and polymorphisms in CARD14 gene].
Dereure O
Ann Dermatol Venereol; 2013 Jan; 140(1):65-6. PubMed ID: 23328365
[No Abstract] [Full Text] [Related]
23. CARD14-associated papulosquamous eruption (CAPE) in pediatric patients: Three additional cases and review of the literature.
Frare CP; Blumstein AJ; Paller AS; Pieretti L; Choate KA; Bowcock AM; Larralde M
Pediatr Dermatol; 2021 Sep; 38(5):1237-1242. PubMed ID: 34448248
[TBL] [Abstract][Full Text] [Related]
24. Whole exome sequencing approach to childhood onset familial erythrodermic psoriasis unravels a novel mutation of CARD14 requiring unusual high doses of ustekinumab.
Signa S; Campione E; Rusmini M; Chiesa S; Grossi A; Omenetti A; Caorsi R; Viglizzo GM; Galluzzo M; Bianchi L; Talamonti M; Orlandi A; Martini A; Ceccherini I; Gattorno M
Pediatr Rheumatol Online J; 2019 Jul; 17(1):38. PubMed ID: 31286971
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment of CARD14-negative juvenile Pityriasis rubra pilaris with Ustekinumab.
Reitmajer M; Forchhammer S; Silber T
J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):e512-e514. PubMed ID: 38084925
[No Abstract] [Full Text] [Related]
26. Successful treatment with ustekinumab in CARD14-associated papulosquamous eruption in a Brazilian child.
Kiszewski AE; De Almeida HL
Dermatol Ther; 2022 Dec; 35(12):e15939. PubMed ID: 36239488
[TBL] [Abstract][Full Text] [Related]
27. Updating and identifying three novel variants of the
Huang Y; Zhang C; Tao L; Zhou J; Zhu J; Yan K; Han L; Huang Q; Shi J; Zhang Z
J Genet; 2020; 99():. PubMed ID: 33622988
[TBL] [Abstract][Full Text] [Related]
28. Autosomal dominant familial generalized pustular psoriasis caused by a CARD14 mutation.
Takeichi T; Kobayashi A; Ogawa E; Okuno Y; Kataoka S; Kono M; Sugiura K; Okuyama R; Akiyama M
Br J Dermatol; 2017 Oct; 177(4):e133-e135. PubMed ID: 28295164
[No Abstract] [Full Text] [Related]
29. Acute generalized exanthematous pustulosis and polyarthritis associated with a novel CARD14 mutation.
Podlipnik S; Castellanos-Moreira R; Florez-Enrich H; Arostegui JI; Mascaró JM
Australas J Dermatol; 2018 Feb; 59(1):e70-e73. PubMed ID: 28776328
[TBL] [Abstract][Full Text] [Related]
30. Rare CARD14 missense variants associated with palmoplantar pustulosis (PPP) in the Chinese Han population.
Fu F; Sun Y; Zhao Q; Yu G; Yang Q; Liu H; Zhang F
Eur J Dermatol; 2019 Feb; 29(1):99-100. PubMed ID: 30998217
[No Abstract] [Full Text] [Related]
31. Variant analysis of CARD14 in a Chinese Han population with psoriasis vulgaris and generalized pustular psoriasis.
Qin P; Zhang Q; Chen M; Fu X; Wang C; Wang Z; Yu G; Yu Y; Li X; Sun Y; Wu W; Yang B; Liu H; Zhang F
J Invest Dermatol; 2014 Dec; 134(12):2994-2996. PubMed ID: 24999592
[No Abstract] [Full Text] [Related]
32. A Review on Pityriasis Rubra Pilaris.
Wang D; Chong VC; Chong WS; Oon HH
Am J Clin Dermatol; 2018 Jun; 19(3):377-390. PubMed ID: 29302927
[TBL] [Abstract][Full Text] [Related]
33. Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris.
Berki DM; Liu L; Choon SE; David Burden A; Griffiths CEM; Navarini AA; Tan ES; Irvine AD; Ranki A; Ogo T; Petrof G; Mahil SK; Duckworth M; Allen MH; Vito P; Trembath RC; McGrath J; Smith CH; Capon F; Barker JN
J Invest Dermatol; 2015 Dec; 135(12):2964-2970. PubMed ID: 26203641
[TBL] [Abstract][Full Text] [Related]
34. CARD14-associated papulosquamous eruption (CAPE) in a toddler responding to treatment with acitretin.
Wong GHZ; Chia SY; Wei H; Rafi'ee K; Koh MJA; Tan EC
Pediatr Dermatol; 2021 Jul; 38(4):970-972. PubMed ID: 34075616
[TBL] [Abstract][Full Text] [Related]
35. Treatment Options for Juvenile Pityriasis Rubra Pilaris.
Guenther J; Novack D; Kamath S; Worswick S
Paediatr Drugs; 2023 Mar; 25(2):151-164. PubMed ID: 36529810
[TBL] [Abstract][Full Text] [Related]
36. [Autoinflammatory diseases in dermatology: DITRA and CAMPS].
Sugiura K
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):169-173. PubMed ID: 28747603
[TBL] [Abstract][Full Text] [Related]
37. Variants of CARD14 are predisposing factors for generalized pustular psoriasis (GPP) with psoriasis vulgaris but not for GPP alone in a Chinese population.
Li L; You J; Fu X; Wang Z; Sun Y; Liu H; Zhang F
Br J Dermatol; 2019 Feb; 180(2):425-426. PubMed ID: 30387497
[No Abstract] [Full Text] [Related]
38. Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options.
Joshi TP; Duvic M
Am J Clin Dermatol; 2024 Mar; 25(2):243-259. PubMed ID: 38159213
[TBL] [Abstract][Full Text] [Related]
39. A novel CARD14 variant, homozygous c.526G>C (p.Asp176His), in an adolescent Japanese patient with palmoplantar pustulosis.
Tobita R; Egusa C; Maeda T; Abe N; Sakai N; Suzuki S; Kawashima H; Hokibara S; Ko J; Okubo Y
Clin Exp Dermatol; 2019 Aug; 44(6):694-696. PubMed ID: 30723930
[No Abstract] [Full Text] [Related]
40. Pityriasis rubra pilaris, a familial condition.
Kint A; De Bie S; Geerts ML; T'Kint R
Arch Belg Dermatol Syphiligr; 1972; 28(4):371-6. PubMed ID: 4670284
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
